SK Biopharm Signs Pharmaceutical Supply Contract Worth 16.3 Billion KRW
[Asia Economy Reporter Park Jihwan] SK Biopharm announced on the 24th that it has signed a pharmaceutical supply contract worth 16.3 billion KRW with SK Life Science.
Hot Picks Today
"You Might Regret Not Buying Now"... Overseas Retail Investors Stirred by News of Record-Breaking Monster Stocks' IPOs
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Mistaken for the Flu, Left Untreated... Death Toll Surges as WHO Declares Emergency (Comprehensive)
- "Concerns Over Expanded Travel Rule"... FIU Holds Closed Meeting with Virtual Asset Industry on Enforcement Decree of the Act on Specified Financial Transaction Information
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
